News

This innovative team approach connects use cases with data sets to provide artificial intelligence (AI) developers with another set of resources for building AI tools to benefit radiology.

This Request for Information is intended to obtain information to formulate a procurement strategy for a data platform to support the National Childhood Cancer Registry, a component of the larger Childhood Cancer Data Initiative.

In partnership with The Cancer Imaging Archive (TCIA), the American Association of Physicists in Medicine released a special virtual issue of Medical Physics in March 2021 titled, “Datasets Hosted in NCI’s Cancer Imaging Archive.” This special issue aims to highlight valuable examples of both Medical Physics Data Set Articles (MPDAs) and publicly available data sets that can be reused for future research endeavors and utilized for addressing emerging scientific or clinical questions.

Attending the 2021 American Association for Cancer Research (AACR) Annual Meeting? Here are a few event and poster sessions you won’t want to miss to learn more about the latest NCI data science, data commons, and cancer research activities.

The U.S. Department of Health and Human Services has launched the “COVID-19 TOPx” technology sprint to develop digital solutions for the effective collection and reporting of COVID-19 diagnostics data. Data scientists, cancer researchers, and the greater public may provide feedback on these solutions in a live virtual demo on April 1, 2021.

The Pediatric Genomic Data Inventory (PGDI) is now available on datascience.cancer.gov for data scientists and cancer researchers. This resource lists known ongoing and completed sequencing projects of pediatric cancer cohorts from the United States and other countries, along with some basic details and reference metadata.

The Human Cancer Models Initiative’s (HCMI’s) Searchable Catalog now has new features that allow users to easily locate models and their case-associated data in the Genomic Data Commons.

NCI’s Office of Cancer Genomics’ data analysis and experimental observations tool—CTD² Dashboard—aims to make cancer-relevant results from the CTD² Network easier to use. Learn more about recent improvements to the Dashboard.

Clinical plasma samples and associated clinical data collected from breast cancer patients by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) are now publicly available research resources.

In collaboration with the National Institute of Allergy and Infectious Diseases and the Center for Disease Control and Prevention, NCI has developed COVID-19 Seroprevalence Hub (COVID-19 SeroHub), a central repository of SARS-CoV-2 seroprevalence studies.